Reported 54,831 shares, down 189 (0.3%) from the prior quarter.
Reported value 4.9%; share count -0.3% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 9734000 |
| 2022-03-31 | 14393000 |
| 2022-06-30 | 15507000 |
| 2022-09-30 | 16165000 |
| 2022-12-31 | 16033066 |
| 2023-03-31 | 17600755 |
| 2023-06-30 | 19560565 |
| 2023-09-30 | 19417106 |
| 2023-12-31 | 22941677 |
| 2024-03-31 | 23631149 |
| 2024-06-30 | 26661964 |
| 2024-09-30 | 26512117 |
| 2024-12-31 | 22993031 |
| 2025-03-31 | 27535920 |
| 2025-06-30 | 24942261 |
| 2025-09-30 | 21616509 |
| 2025-12-31 | 24862193 |
| 2026-03-31 | 24745392 |
| 2026-06-30 | 27330505 |
| 2026-09-30 | 28666115 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Reduced | 54,831 | -189 (-0.3%) | 2.01% | $28,666,115 | 2026-11-03 | |
| Q2 2026 | Reduced | 55,020 | -395 (-0.7%) | 1.86% | $27,330,505 | 2026-08-07 | |
| Q1 2026 | Added | 55,415 | +576 (1.1%) | 1.95% | $24,745,392 | 2026-05-13 | |
| Q4 2025 | Reduced | 54,839 | -355 (-0.6%) | 1.93% | $24,862,193 | 2026-02-10 | |
| Q3 2025 | Reduced | 55,194 | -830 (-1.5%) | 1.67% | $21,616,509 | 2025-11-06 | |
| Q2 2025 | Reduced | 56,024 | -772 (-1.4%) | 2.15% | $24,942,261 | 2025-08-11 | |
| Q1 2025 | Reduced | 56,796 | -301 (-0.5%) | 2.53% | $27,535,920 | 2025-05-05 | |
| Q4 2024 | Added | 57,097 | +92 (0.2%) | 2.03% | $22,993,031 | 2025-02-10 | |
| Q3 2024 | Added | 57,005 | +123 (0.2%) | 2.31% | $26,512,117 | 2024-11-12 | |
| Q2 2024 | Added | 56,882 | +350 (0.6%) | 2.48% | $26,661,964 | 2024-08-07 | |
| Q1 2024 | Added | 56,532 | +150 (0.3%) | 2.23% | $23,631,149 | 2024-05-09 | |
| Q4 2023 | Added | 56,382 | +544 (1.0%) | 2.4% | $22,941,677 | 2024-02-07 | |
| Q3 2023 | Added | 55,838 | +254 (0.5%) | 2.29% | $19,417,106 | 2023-11-09 | |
| Q2 2023 | Reduced | 55,584 | -279 (-0.5%) | 2.21% | $19,560,565 | 2023-08-09 | |
| Q1 2023 | Added | 55,863 | +343 (0.6%) | 2.14% | $17,600,755 | 2023-05-09 | |
| Q4 2022 | Reduced | 55,520 | -310 (-0.6%) | 2.01% | $16,033,066 | 2023-02-07 | |
| Q3 2022 | Added | 55,830 | +799 (1.5%) | 2.15% | $16,165,000 | 2022-11-08 | |
| Q2 2022 | Reduced | 55,031 | -122 (-0.2%) | 1.95% | $15,507,000 | 2022-08-04 | |
| Q1 2022 | Added | 55,153 | +10,825 (24.4%) | 1.52% | $14,393,000 | 2022-05-12 | |
| Q4 2021 | Added | 44,328 | +9,654 (27.8%) | 1.0% | $9,734,000 | 2022-02-09 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
1896 managers reported VERTEX PHARMACEUTICALS INC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Capital World Investors | Reduced | 25,966,793 | -148,221 | 1.65% | $13,575,850,288 | 54 qtrs |
| BlackRock Inc | Reduced | 23,803,111 | -306,262 | 0.18% | $12,444,504,450 | 9 qtrs |
| Capital Research Global Investors | Reduced | 17,814,302 | -1,676,335 | 1.32% | $9,313,657,644 | 15 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Added | 16,595,978 | +15,265 | 0.18% | $8,676,543,258 | 3 qtrs |
| STATE STREET CORPORATION | Added | 12,024,456 | +152,997 | 0.18% | $6,286,505,841 | 54 qtrs |
| Invesco Ltd | Added | 8,280,998 | +237,946 | 0.34% | $4,329,388,595 | 54 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 6,081,969 | +64,121 | 0.16% | $3,165,506,588 | 54 qtrs |
| JPMorgan Chase & Co | Reduced | 5,691,686 | -825,914 | 0.16% | $2,997,982,781 | 54 qtrs |
| Capital International Investors | Added | 5,059,186 | +364,042 | 0.55% | $2,645,058,681 | 8 qtrs |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Added | 4,944,618 | +65,631 | 0.12% | $2,585,095,737 | 3 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 03, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 54,831
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.